Neurogene Financial Overview
Neurogene's market cap is currently $296.47M. The company's EPS TTM is $-0.99; its P/E ratio is -4.35; Neurogene is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.
